Plain-English translation of NCT06656390 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This is one of the first times this treatment has been tested in people.
This is an early-stage trial testing a new medication called for people with advanced solid tumors. Researchers will gradually increase the dose to find the safest level and see how well this treatment works. The study will eventually enroll about 202 participants across multiple hospitals.
This medication is brand new in human testing, and doctors need to understand how safe it is, what side effects it might cause, and whether it can help shrink tumors. This trial will help establish the right dose for future research.
You likely qualify if…
You likely don't qualify if…
The study has two phases: first, researchers will gradually increase doses in small groups to find the safest amount (Part A), then enroll more people at that safe dose level (Part B). You would receive injections of the medication and have regular visits for blood tests, scans, and check-ups to monitor how the treatment is working and any side effects you might experience. The exact length depends on how you respond to treatment.
AI-generated summary from trial data · Oct 12, 2026 · Not medical advice
United States
Australia